Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling modifications necessary to reduce potential exemption petitions -- NDMA.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABELING RULE MODIFICATIONS NECESSARY TO REDUCE EXEMPTION PETITIONS that may be submitted to FDA, the Nonprescription Drug Manufacturers Association says in March 19 comments to the agency. Specifically, the association proposes use of 5-point type, elimination of leading, use of "any" sans serif font and the ability to put warnings on more than one information panel. In its comments, NDMA also expands its support for a small package exemption from cosmetic-drugs to all OTCs.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel